• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚农村地区的糖尿病肾病:预防、管理、治疗及未来方向。

Diabetic kidney disease in rural Australia: prevention, management, treatment and way forward.

作者信息

Ross Allen G, Mondal Utpal K, Anyasodor Anayochukwu E, Mahmood Shakeel, Astawesegn Feleke H, Huda M Mamun, Thapa Subash, Aychiluhm Setognal B, Giri Santosh, Rahman Md Ferdous, Shiddiky Muhammad J A, Moni Mohammad A, Ahmed Kedir Y

机构信息

Rural Health Research Institute, Charles Sturt University, Orange, NSW, Australia.

出版信息

Front Med (Lausanne). 2025 Jun 12;12:1561566. doi: 10.3389/fmed.2025.1561566. eCollection 2025.

DOI:10.3389/fmed.2025.1561566
PMID:40575571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12198140/
Abstract

Diabetic kidney disease is a significant microvascular complication associated with chronic diabetes, contributing substantially to the overall health burden of the disease. This perspective focusses on evaluating the most recent advancements in screening techniques, prevention, and treatment strategies along with new advances in the field. A comprehensive literature search was conducted across PubMed, Scopus and Google Scholar databases to identify and synthesize recent evidence. In Australia, chronic kidney disease (CKD) was responsible for approximately two million hospital admissions, accounting for 18% of all hospitalizations in 2021-22. In remote areas, 17,100 CKD-related hospitalizations were reported during this period, with residents being three times more likely to be hospitalized for CKD compared to those living in major cities. Among First Nations people, the burden was 7.8 times higher than that of non-Indigenous populations. Advocacy for policy changes to address healthcare disparities in rural and remote Australia is crucial.

摘要

糖尿病肾病是一种与慢性糖尿病相关的重要微血管并发症,对该疾病的整体健康负担有很大影响。这一观点聚焦于评估筛查技术、预防和治疗策略的最新进展以及该领域的新进展。通过对PubMed、Scopus和谷歌学术数据库进行全面的文献检索,以识别和综合近期证据。在澳大利亚,慢性肾脏病(CKD)导致了约200万例住院病例,占2021 - 2022年所有住院病例的18%。在此期间,偏远地区报告了17100例与CKD相关的住院病例,与居住在大城市的居民相比,偏远地区居民因CKD住院的可能性高出三倍。在原住民中,这一负担比非原住民高出7.8倍。倡导政策变革以解决澳大利亚农村和偏远地区的医疗保健差距至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eefd/12198140/6c8fb4b34f4a/fmed-12-1561566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eefd/12198140/18de20f5689f/fmed-12-1561566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eefd/12198140/6c8fb4b34f4a/fmed-12-1561566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eefd/12198140/18de20f5689f/fmed-12-1561566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eefd/12198140/6c8fb4b34f4a/fmed-12-1561566-g002.jpg

相似文献

1
Diabetic kidney disease in rural Australia: prevention, management, treatment and way forward.澳大利亚农村地区的糖尿病肾病:预防、管理、治疗及未来方向。
Front Med (Lausanne). 2025 Jun 12;12:1561566. doi: 10.3389/fmed.2025.1561566. eCollection 2025.
2
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
3
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
4
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
7
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.糖尿病肾病的多学科管理:一项系统评价与荟萃分析
JBI Database System Rev Implement Rep. 2016 Jul;14(7):169-207. doi: 10.11124/JBISRIR-2016-003011.
8
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
The Use of mHealth Apps for the Assessment and Management of Diabetes-Related Foot Health Outcomes: Systematic Review.移动医疗应用程序在评估和管理糖尿病相关足部健康结局中的应用:系统评价。
J Med Internet Res. 2023 Oct 4;25:e47608. doi: 10.2196/47608.

本文引用的文献

1
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2025.1. 改善人群护理与促进健康:2025年糖尿病护理标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S14-S26. doi: 10.2337/dc25-S001.
2
Improving the Detection and Management of Kidney Health in Primary Care.改善基层医疗中肾脏健康的检测与管理。
J Patient Exp. 2024 Jun 13;11:23743735241256464. doi: 10.1177/23743735241256464. eCollection 2024.
3
Recommendations for culturally safe clinical kidney care for First Nations Australians: a guideline summary.
推荐为澳大利亚原住民提供文化安全的临床肾脏护理:指南摘要。
Med J Aust. 2023 Oct 16;219(8):374-385. doi: 10.5694/mja2.52114.
4
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.KDIGO 2022慢性肾脏病糖尿病管理临床实践指南
Kidney Int. 2022 Nov;102(5S):S1-S127. doi: 10.1016/j.kint.2022.06.008.
5
Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis.1型糖尿病患者中代谢综合征的全球患病率:一项系统评价和荟萃分析。
Diabetol Metab Syndr. 2021 Mar 2;13(1):25. doi: 10.1186/s13098-021-00641-8.
6
Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets.糖尿病肾病:新的分子机制与治疗靶点
Front Pharmacol. 2020 Dec 21;11:586892. doi: 10.3389/fphar.2020.586892. eCollection 2020.
7
11. Microvascular Complications and Foot Care: .11. 微血管并发症和足部护理: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S151-S167. doi: 10.2337/dc21-S011.
8
10. Cardiovascular Disease and Risk Management: .10. 心血管疾病与风险管理: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S125-S150. doi: 10.2337/dc21-S010.
9
9. Pharmacologic Approaches to Glycemic Treatment: .9. 血糖治疗的药物学方法: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S111-S124. doi: 10.2337/dc21-S009.
10
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: .4. 全面的医学评估和合并症评估: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S40-S52. doi: 10.2337/dc21-S004.